Exploration of target molecules for prostate cancer gene therapy
Authors:
- 21 May 2007
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 67 (11) , 1163-1173
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Carcinoembryonic Antigen–Targeted Selective Gene Therapy for Gastric Cancer through FZ33 Fiber-Modified Adenovirus VectorsClinical Cancer Research, 2006
- Mechanisms Leading to the Development of Hormone-Resistant Prostate CancerUrologic Clinics of North America, 2006
- Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissueHistopathology, 2005
- Gene therapy for prostate cancer: Current strategies and new cell‐based approachesThe Prostate, 2005
- Evidence-based Medical Perspectives: The Evolving Role of PSA for Early Detection, Monitoring of Treatment Response, and as a Surrogate End Point of Efficacy for Interventions in Men with Different Clinical Risk States for the Prevention and Progression of Prostate CancerAmerican Journal of Therapeutics, 2004
- Modulation of phenotype of human prostatic stromal cells by transforming growth factor‐betasThe Prostate, 2003
- Antibody-Mediated Targeting of an Adenovirus Vector Modified To Contain a Synthetic Immunoglobulin G-Binding Domain in the CapsidJournal of Virology, 2003
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- Adenovirus‐Mediated in Vivo Gene TransferAnnals of the New York Academy of Sciences, 1994